This study found that NKAPL downregulation in NSCLC is associated with poor prognosis and hypermethylation of its promoter. High NKAPL expression inhibits NSCLC cell proliferation, migration, and invasion. NKAPL enhances TRIM21 protein stability, leading to suppression of the NF-κB signaling pathway.
Pyruvate alleviates ulcerative colitis symptoms by targeting cPLA2, suppressing TNFα/NFκB signaling and reducing inflammation. Pyruvate preserves intestinal mucosal barrier integrity and normalizes tight junction proteins.
Researchers employed a novel validation-based insertional mutagenesis technique to identify genes conferring carboplatin resistance in human epithelial ovarian cancer cells. HN1L was found to enhance resistance by activating NF-κB signaling, and targeting this gene may represent a promising strategy for overcoming platinum resistance.
The review highlights the indispensable value of model organisms in understanding disease pathogenesis, revealing conserved genetic pathways across species. This knowledge accelerates the identification of candidate disease genes and the testing of therapeutic strategies for rare genetic disorders.
The tumor microenvironment in osteosarcoma plays a critical role in disease progression and treatment resistance. Targeting the interplay between cancer cells, immune components, stromal elements, and extracellular matrix is crucial for developing effective treatments.
Recent findings reveal TET1's dual role in disease progression, inhibiting malignant cell growth in certain cancers while driving oncogenic pathways in others. Abnormal TET1 activity disrupts epigenetic mechanisms, contributing to neurological disorders, metabolic diseases, and autoimmune conditions.
A newly developed electrochromic harvester can toggle between solar heating and radiative cooling, providing programmable thermal regulation without sustained power input. This technology has the potential to transform HVAC strategies across industries, offering self-regulating thermal envelopes and reducing energy consumption.
Researchers uncover the crucial role of dermal T cell immunity in regulating hair follicle regeneration and addressing immune-mediated alopecia. The intricate relationship between T cells and hair follicle regeneration is driven by key regulatory signaling pathways that dictate the activity of epithelial stem cells.
Ribosome biogenesis is crucial for liver regeneration, hepatitis C virus infection, nonalcoholic fatty liver disease, liver fibrosis, cirrhosis, and hepatocellular carcinoma. Targeted therapies targeting ribosome biogenesis may offer new treatment options for chronic liver diseases and liver cancer.
The review highlights the significance of fusion genes across various cancers, including hematological malignancies, lung cancer, thyroid cancer, and prostate cancer. Fusion genes disrupt normal cellular processes, leading to uncontrolled proliferation and metastatic potential.
LINE-1 elements, retrotransposons actively transcribed in zygotes, facilitate chromatin architecture opening and interact with epigenetic regulators to maintain genome stability. Understanding LINE-1 regulation could lead to novel therapeutic strategies in reproductive medicine and age-related disorders.
The review explores the epigenetic regulatory network of lncRNAs in hepatocellular carcinoma, highlighting DNA methylation, histone modifications, RNA methylation, and microRNAs. These mechanisms drive liver cancer progression, offering insights for diagnostic and therapeutic strategies.
Bio Integration has a new institutional partner, University of South China's Institute of Sports Medicine, Fudan University, to support its interdisciplinary research in biomaterials, regenerative medicine, and translational healthcare. Professor Chaozong Liu joins as Co-Editor-in-Chief to shape the journal's editorial direction.
The study highlights the importance of pro-inflammatory cytokines and CXC chemokines in tumor development and immune system modulation. Age-related changes in the tumor microenvironment, including extracellular matrix stiffening and inflammatory immune mediator accumulation, contribute to tumor growth, metastasis, and immune evasion.
FGF8 regulates embryonic development, craniofacial structures, limb formation, kidney development, heart development, and the nervous system. Disruptions in its function lead to developmental disorders, including skeletal malformations and congenital anomalies.
TsRNAs emerge as promising biomarkers for a wide range of diseases, particularly cancers. These non-coding RNA fragments exhibit remarkable stability in diverse body fluids and show disease-specific expression patterns.
Emerging research highlights the pivotal role of circular RNAs in disease progression, influencing tumor proliferation, metastasis, immune evasion, and drug resistance. Specific circRNAs have been identified as key players in HCC progression, affecting crucial signaling pathways like PI3K/Akt, Wnt/β-catenin, and NF-κB.
IGF2BP1 binds to methylated mRNA, stabilizing oncogenic transcripts and promoting cancer progression. Elevated expression of IGF2BP1 correlates with poor prognosis and therapy resistance in multiple cancers.
PDX models accurately mimic human tumors, offering a powerful preclinical platform for testing novel therapies. These models have demonstrated significant promise in various types of cancer research.
Breast cancer's metabolic reprogramming holds novel treatment avenues, targeting glycolysis, glutamine, and lipid metabolism to exploit dependencies. Emerging strategies aim to enhance immunotherapy by modulating metabolic pathways.
This study identifies ageing-related differentially expressed genes (ARDEGs) as potential biomarkers for heart failure with preserved ejection fraction (HFpEF). The ARDEGs were found to be associated with metabolic and immune functions, suggesting a critical role in immune regulation in HFpEF.
A study reveals that APPswe promotes osteogenic differentiation of mesenchymal stem cells by regulating the Notch pathway, while its extracellular segment blocks cell proliferation and migration. This suggests a potential role for APPswe in bone formation and treatment of bone loss in Alzheimer's patients.
Researchers leveraged CRISPR/CasRx to silence Ctnnb1 and Smo, two genes involved in osteoarthritis development. Simultaneous knockdown of both genes effectively mitigated joint structure degeneration, highlighting the potential of RNA-based gene therapies for OA management.
A recent study found that MET mutations are associated with enhanced tumor immunogenicity, increased immune cell infiltration, and improved response rates to immune checkpoint blockade. Certain single base substitutions identified as robust predictive biomarkers for survival in pan-cancer immunotherapy.
This study reveals TUG1's central role in CHS progression through its interaction with EZH2, influencing tumor growth, migration, and invasion. Exosomal TUG1 also enhances M2 macrophage polarization, promoting tumorigenesis.
Research reveals NADK tetramer defective mutants enhance tumor progression and chemotherapy resistance by regulating enzyme activity. Mutations impacting tetramer formation suppress activity, while others promote cancer cell growth and sensitivity to chemotherapy.
A new study identifies CSMD1 as a novel gene associated with generalized epilepsies, including developmental and epileptic encephalopathy. The research found that CSMD1 variants are more damaging and exhibit lower minor allele frequencies in DEE cases compared to IGE cases.
Bcl6 inhibits Treg cell lineage stability, allowing for increased CD8+ T cell infiltration and enhanced anti-tumor response. Bcl6 inhibitor FX1 also synergizes with PD-1/PD-L1 ICB therapy.
HER3 plays a major contributor role to the survival and spread of various solid tumors, including breast, lung, colorectal, pancreatic, and gynecologic cancers. HER3 functions through interaction with other ErbB receptors, forming potent signaling pairs that drive cell survival, proliferation, and metastasis.
Mitochondrial DNA editing has emerged as a revolutionary approach in the fight against neurodegenerative diseases. The dysfunction of mitochondria, triggered by mutations in mtDNA, is recognized as a pivotal factor contributing to conditions like Parkinson's disease, Alzheimer's disease, and Huntington's disease.
Researchers are devising strategies to target MYC directly by interfering with the MYC-MAX protein complex. Promising compounds have demonstrated early clinical potential by disrupting this interaction and halting tumor proliferation.
RANBP2 is a SUMO E3 ligase involved in post-translational modification and tumorigenesis, linked to various solid malignancies. Targeting RANBP2 may open new avenues for therapeutic intervention, but further research is needed to validate its clinical potential.
Interactions between RNA-binding proteins (RBPs) and circular RNAs (circRNAs) regulate various cancer-related processes, including tumor proliferation and immune evasion. The circRNA-RBP network holds promise as a target for innovative cancer therapies.
A new study reveals that SIRT5 promotes BMP9-induced osteogenic differentiation by stabilizing HIF-1α. The research suggests targeting SIRT5 could enhance bone regeneration and is a promising approach for clinical applications.
A new study published in Genes & Diseases journal introduces a novel therapeutic approach for acute myeloid leukemia (AML) using the METTL3 degrader ZW27941. The research team found that ZW27941 exhibited potent anti-leukemic activity and synergistic effects with existing AML therapies.
Researchers found that MCT4 inhibition up-regulates genes involved in triglyceride and fatty acid synthesis, increasing intracellular lipid accumulation. Overexpression of MCT4 reduces lipid accumulation by down-regulating hepatic lipid metabolism-related genes.
A new study reveals that exosomal lnc-TAF12–2:1 promotes bladder cancer progression through the miR-7847–3p/ASB12 regulatory axis. Silencing of lnc-TAF12–2:1 inhibited tumor growth and induced apoptosis, while its overexpression enhanced cell proliferation and migration.
Researchers found that SLC27A5 downregulates PABPC1, reducing the utilization frequency of METTL14-dPAS and shifting to shorter 3'UTRs, leading to HCC stemness inhibition. This study suggests targeting SLC27A5-induced APA or METTL14-US as a novel therapeutic approach for impeding HCC progression.
A new study reveals the spatial organization and tumor microenvironment of primary testicular diffuse large B-cell lymphomas. The research identifies exhausted CD8+ T cells and B1 cells as playing a role in tumor progression, while E2F and CREB inhibition shows promise as novel therapeutic targets.
This review highlights how fatty acid oxidation (FAO) fuels tumor growth, survival, and metastasis by modulating the tumor microenvironment. FAO is also involved in chemotherapy resistance, particularly in breast cancer, glioblastoma, and ovarian cancer.
Glutathione S-transferases play a critical role in human health, influencing disease development, drug metabolism, and therapeutic interventions. Genetic variations in GSTs can lead to oxidative stress, DNA damage, and resistance to apoptosis, making them key players in disease pathogenesis.
This review highlights the critical role of epigenetics in nuclear receptor function, affecting metabolic and hormone-driven disorders. Emerging therapies targeting epigenetic mechanisms hold promise for restoring proper nuclear receptor function.
Recent research has focused on neddylation modification as a key driver of tumor cell proliferation, migration, and survival. Neddylation inhibitors have demonstrated significant efficacy in disrupting cancer cell growth by selectively inhibiting the neddylation pathway.
Researchers identified miR-146b as a key regulator of beta-cell decline during obesity-to-T2DM progression. The study showed that miR-146b suppresses the expression of Btg2, leading to increased apoptosis and decreased insulin synthesis and secretion.
Researchers discovered novel COVID-19-specific chimeric RNAs in whole blood of patients, differing between symptomatic and asymptomatic cases. These chimeric RNAs have an additional layer of transcriptional control and may serve as valuable biomarkers for early-stage viral infection.
Researchers identified IRF8 as a crucial factor modulating hepatic lipid homeostasis and hepatic steatosis in NAFLD models. The study reveals that targeting the IRF8-BMAL1-PPARγ axis could offer promising therapeutic strategies for treating NAFLD and related metabolic disorders.
Researchers created a world's first micrometer-level 3D multimodal atlas integrating cranium, functional brain regions, cerebral vasculature, and invasive brain-computer interface devices. The study utilized mixed reality for interactive visualization, enabling intuitive exploration of brain-computer interfaces and brain tissues.
A new study reveals the molecular mechanism of lymph node metastasis in gallbladder cancer, identifying eEF1A2 and its K36 trimethylation as prognostic markers. The EEF1AKMT4-eEF1A2K36me3 axis promotes ribosome protein synthesis, enhancing tumor growth and metastasis.
The article provides a comprehensive overview of anaplastic thyroid cancer's molecular mechanisms, diagnostic approaches, and therapeutic strategies. Key findings include the significance of targeted therapies, such as BRAF and MEK inhibitors, and the potential of immunotherapy and novel agents to enhance treatment outcomes.
Citrullination, driven by peptidyl arginine deiminases (PADs), converts arginine to citrulline, altering protein structure and function. PAD2 and PAD4 play pivotal roles in epigenetic regulation, affecting transcriptional activity through histone modification and interaction with transcription factors.